Searched for
ROBUST PATENT PORTFOLIO
Kiran Mazumdar-Shaw names niece Claire as successor, targets semaglutide push from FY28; debt cut to $1.1 billionBiocon's Executive Chairperson, Kiran Mazumdar-Shaw, outlined a five-year leadership transition with her niece, Claire Mazumdar, as success...- Boom or bust? Analysts reveal what lies ahead for India Inc in FY27 amid Iran warIndian businesses brace for 2026-27 with geopolitical tensions and AI reshaping industries. While core sectors show stability, policy shift...
- Ajanta Pharma, Sun Pharma poised to tap GLP-1 opportunity amid market shift: Siddhartha KhemkaIndia's metabolic therapy market is transforming post-semaglutide patent expiry, shifting to a competitive, volume-driven model. With signi...
- Advent International to acquire stake in Felix PharmaceuticalsAdvent International is set to invest $175 million in Felix Pharmaceuticals, acquiring a significant minority stake. Felix Pharma, a Dublin...
- Piramal Pharma posts Rs 4 crore net profit in Q3FY25Piramal Pharma on Tuesday reported net profit of Rs 4 crore in Q3FY25.
- 3 reasons why Indian pharma is getting ready for unstoppable growthFor Indian pharmaceutical companies, this scenario presents a distinct opportunity. Leveraging their established expertise and leadership i...
- Affle India is this week's top stock; why analysts are bullishThe management aims for over 20% revenue growth in 2024-25 and is optimistic about better pricing and margin improvement. Analysts expect t...
- Best Agrolife acquires 100 pc stake in Sudarshan Farm Chemicals for Rs 139 croreThe acquisition will enable BAL to leverage SFCL's proficiency in developing cost-effective and distinctive manufacturing routes for off-pa...
- India Inc leans on legal-tech firms to protect IPR as it expands to mature geographiesCompanies in the sectors including pharmaceutical, information technology, automobile and even conventional manufacturing companies are app...
- Buy PI Industries, target price Rs 3460: JM FinancialPI Industries Ltd., incorporated in the year 1946, is a Large Cap company (having a market cap of Rs 44289.55 Crore) operating in Pesticide...
- Aurobindo Pharma to buy Portugal's Generis for 135 mn euroAurobindo Pharma has inked an agreement through its subsidiary Agile Pharma BV Netherlands to acquire Generis Farmaceutica.
- L&T Technology Q2 net up by 19.7% at Rs 111.9 croreThe total income of the company increased by 5 per cent to Rs 837.6 crore during the reported quarter from Rs 797.3 crore in the same perio...
- India won't succumb to any pressure on IPR issues: Nirmala SitharamanSitharaman said that India is working on a case based on the fact that several states in the US are also possibly giving a domestic content...
- US exports may drive top Indian pharma cos to grow 20% in 2013"We believe that top players of the sector will continue to grow strongly in 2013, primarily led by exports.
- Patent war: Who gained and who lost in Apple-Samsung dispute?Apple's landmark victory over Samsung in the patent infringement case affirms the company's claim that some of the key Android features vio...
- Continue to be positive on pharmaceuticals: Capital Portfolio AdvisorsIf you look at the demand environment both locally and internationally, it continues to be reasonably robust.
- Dr Reddy’s outlook robust, upgrades ratings to overweight: JPMorganJPMorgan has upgraded the ratings of Dr Reddy’s Laboratories to ‘Overweight’ from ‘Neutral’, on the back of robust outlook.
- Lava International expects Rs 1,000 cr business by March'12Director S N Rai said Lava is looking for expansion of business in Africa and looking at new geographies namely Peru and Chile.
- 'We will focus on innovation'Ramesh Subramanian of Merck & Co, Inc says the firm's growth in India will be steered by new business models.
- Wockhardt buys French co for Rs 1,090 crWockhardt has acquired Negma Laboratories in cash - a deal that would give it access to the European mkt.
Load More
